| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| BERKSHIRE HATHAWAY CL-B NEW | AT COST | 809,603 | 1,069,980 |
| VANGUARD DIVIDEND APPRECIATION | AT COST | 9,182,916 | 10,224,077 |
| VANGUARD GROWTH ETF | AT COST | 373,638 | 497,408 |
| VANGUARD HIGH DIVIDEND YIELD ETF | AT COST | 7,011,742 | 7,306,184 |
| VANGUARD MID-CAP ETF INDEX | AT COST | 621,101 | 697,920 |
| VANGUARD S&P 500 ETF | AT COST | 6,108,457 | 7,425,600 |
| VANGUARD SMALL CAP ETF | AT COST | 612,727 | 693,323 |
| VANGUARD VALUE ETF INDEX | AT COST | 749,993 | 825,988 |
| BLACKROCK HEALTH SCIENCE OPP I | AT COST | 2,770,173 | 6,996,000 |
| OAKMARK EQUITY & INC INST | AT COST | 8,575,527 | 11,032,051 |
| ACCRUED INTEREST | AT COST | 209,956 | 209,956 |
| Description | Amount |
|---|---|
| FMV DIFFERENCE IN CONTRIBUTED ASSETS | 5,505,095 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ADVISOR FEES | 86,152 | 86,152 | 0 |